Michael T. McCabe
University of Pittsburgh(US)South College(US)University of Rochester Medical Center(US)GlaxoSmithKline (United States)(US)
Publications by Year
Research Areas
Epigenetics and DNA Methylation, Cancer-related gene regulation, RNA modifications and cancer, Lung Cancer Treatments and Mutations, Protein Degradation and Inhibitors
Most-Cited Works
- → EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations(2012)1,779 cited
- → EZH2 Is Required for Germinal Center Formation and Somatic EZH2 Mutations Promote Lymphoid Transformation(2013)832 cited
- → An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer(2019)618 cited
- → Reductive carboxylation supports redox homeostasis during anchorage-independent growth(2016)592 cited
- → Natural Mutagenesis of Human Genomes by Endogenous Retrotransposons(2010)557 cited
- → A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLC(2015)503 cited